Biotech
Endeavor BioMedicines
Endeavor BioMedicines raises $132.5M Series C at $650M valuation
$132.5M
Total Raised
Series C
Latest Round
2019
Founded
80+
Employees
San Diego, CA
1 min read
Quick Facts
Valuation
$650M
Latest Round Size
$132.5M
Latest Round Date
April 2024
Endeavor BioMedicines: Series C Funding Round
Endeavor BioMedicines has successfully raised $132.5M in Series C funding, reaching a valuation of $650M.
Company Overview
Developing medicines for idiopathic pulmonary fibrosis
Funding Details
The Series C round was led by AyurMaya, with participation from Polaris Partners.
Company Information
- Headquarters: San Diego, CA
- Founded: 2019
- Employees: 80+
- Category: Biotech
Investment
Endeavor BioMedicines plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- AyurMaya: Verified investor in Series C
- Polaris Partners: Verified investor in Series C
Key Investors
AyurMaya
Lead Investor
Verified investor in Series C
Polaris Partners
Investor
Verified investor in Series C
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M